Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HY07121 in Advanced Solid Tumors
NCT07789327Phase 2Not yet recruiting
- Sponsor
- Sichuan Huiyu Pharmaceuticals
- Start
- Sep 2026
- Primary completion
- Apr 2028
01
Overview
A Phase 2 trial of HY-07121 in solid tumor, sponsored by Sichuan Huiyu Pharmaceuticals. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
HY-07121
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07789327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07789327.